PATENT CLAIM ANALYSIS

Application Number: 15903038
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "400000"]

Abstract:
Provided is a composition for percutaneous absorption containing testosterone and one or more organic solvents selected from the group consisting of propylene glycol, 1,3-butylene glycol, dipropylene glycol and polyethylene glycol, in which a total content of the organic solvents with respect to a total amount of the composition for percutaneous absorption is from 60% by mass to 90% by mass, and in which a content of a monohydric alcohol having 2 to 4 carbon atoms with respect to the total amount of the composition for percutaneous absorption is equal to or less than 10% by mass.

Claim (Index 7):
The composition for percutaneous absorption according to  claim 1 , wherein the organic solvents include propylene glycol.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 2.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13106530', '11371042', '14307085', '14177765', '15081402']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7139835780484356
- 35 USC 102 Novelty (BERT): 0.4777915053389698
- Combined Prediction Score: 0.6903643707774891
- Mean Citation Score: 179.746304
- Max Citation Score: 186.63528
- Similarity Product: 143.45865326269626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test